Skip to main content

Table 5 Correlation between radiological response and PFS

From: Prospective comparison of various radiological response criteria and pathological response to preoperative chemotherapy and survival in operable high-grade soft tissue sarcomas in the Japan Clinical Oncology Group study JCOG0304

  5-year PFS of CR/PR/MR (95% CI) 5-year PFS of SD/PD (95% CI) HR (95% CI) p value C-index (95% CI)
RECIST 66.7% (33.7%–86.0%) 66.7% (52.9%–77.3%) 0.99 (0.34–2.92) 0.99 0.50 (0.23–0.77)
Modified RECIST 66.7% (37.5%–84.6%) 66.7% (52.4%–77.5%) 1.00 (0.37–2.70) 1.00 0.52 (0.28–0.77)
WHO 66.7% (37.5%–84.6%) 66.7% (52.4%–77.5%) 1.00 (0.37–2.70) 1.00 0.52 (0.28–0.77)
JOA 60.0% (38.4%–76.1%) 70.5% (54.6%–81.6%) 1.41 (0.62–3.21) 0.42 0.56 (0.36–0.77)
Modified Choi 59.3% (38.6%–75.0%) 71.4% (55.2%–82.6%) 1.54 (0.68–3.49) 0.30 0.61 (0.42–0.81)
  1. CR complete response, PR partial response, MR minor response, SD stable disease, PD progressive disease, HR hazard ratio